Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP902388.RALekM-s3qaVrU977HamoFnqLQeH-G3JUH0GYG55XBjOc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP902388.RALekM-s3qaVrU977HamoFnqLQeH-G3JUH0GYG55XBjOc130_assertion type Assertion NP902388.RALekM-s3qaVrU977HamoFnqLQeH-G3JUH0GYG55XBjOc130_head.
- NP902388.RALekM-s3qaVrU977HamoFnqLQeH-G3JUH0GYG55XBjOc130_assertion description "[Treatment with 101F6 nanoparticle-mediated gene transfer in combination with a subpharmacologic dose (200-500 micromol/L) of ascorbate synergistically and selectively inhibited lung cancer cell growth in vitro.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP902388.RALekM-s3qaVrU977HamoFnqLQeH-G3JUH0GYG55XBjOc130_provenance.
- NP902388.RALekM-s3qaVrU977HamoFnqLQeH-G3JUH0GYG55XBjOc130_assertion evidence source_evidence_literature NP902388.RALekM-s3qaVrU977HamoFnqLQeH-G3JUH0GYG55XBjOc130_provenance.
- NP902388.RALekM-s3qaVrU977HamoFnqLQeH-G3JUH0GYG55XBjOc130_assertion SIO_000772 17616688 NP902388.RALekM-s3qaVrU977HamoFnqLQeH-G3JUH0GYG55XBjOc130_provenance.
- NP902388.RALekM-s3qaVrU977HamoFnqLQeH-G3JUH0GYG55XBjOc130_assertion wasDerivedFrom befree-20140225 NP902388.RALekM-s3qaVrU977HamoFnqLQeH-G3JUH0GYG55XBjOc130_provenance.
- NP902388.RALekM-s3qaVrU977HamoFnqLQeH-G3JUH0GYG55XBjOc130_assertion wasGeneratedBy ECO_0000203 NP902388.RALekM-s3qaVrU977HamoFnqLQeH-G3JUH0GYG55XBjOc130_provenance.